Acute PresentatiOn of CoLorectaL Cancer: an internatiOnal Snapshot
Launched by EUROPEAN STUDENT RESEARCH NETWORK · Nov 30, 2022
Trial Information
Current as of January 14, 2025
Completed
Keywords
ClinConnect Summary
Primary aim: Describe the variation in the operative and non-operative management of emergency presentations of colon and rectal cancer in an international cohort.
Secondary aims:
* Identify risk factors for mortality (intraoperatively, at 30-days and at 90-days) and ostomy rates (at 30- and 90-days) in patients deemed for active management (i.e., not for palliative management) to develop a risk prediction model
* Validate risk criteria of large bowel obstruction in patients with previously known colorectal cancer undergoing neoadjuvant chemotherapy or awaiting elective surgery
Who?
* P...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patient pathology: Patients admitted to the hospital acutely with primary colon AND/OR rectal adenocarcinoma and referred to general/colorectal surgical departments:
- • Patients who are operated on for curative/palliative treatment of colorectal cancer
- • Patients who are referred to general surgery for assessment (irrespective of if they proceed to surgery)
- • New diagnoses of colorectal cancer
- • Extent of cancer: All patients including extra-abdominal metastatic, intra-abdominal metastatic and non-metastatic disease
- • Known cancer: Patients presenting for the first time with colorectal cancer AND/OR known colorectal cancer diagnosis with progression of disease. i.e. obstruction of known colorectal cancer
- • Patient presentation: Symptomatic presentation of colorectal cancer i.e. large bowel obstruction, haemorrhage, perforation
- Exclusion Criteria:
- • Presenting for side effects of cancer treatment
- • Patients with secondary cancers
- • Previously included in the study
About European Student Research Network
The European Student Research Network (ESRN) is a collaborative initiative aimed at advancing clinical research through the engagement and empowerment of students across Europe. By fostering a multidisciplinary approach, ESRN facilitates innovative research projects that address pressing health challenges, while providing students with hands-on experience in clinical trial design, implementation, and analysis. The network emphasizes ethical research practices and aims to cultivate a new generation of skilled researchers equipped to contribute to the evolving landscape of medical science. Through partnerships with academic institutions and healthcare organizations, ESRN is dedicated to promoting excellence in research and enhancing the quality of healthcare outcomes across the continent.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aberdeen, Ireland, United Kingdom
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials